{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} CRNI® Recertification Units & CE Credit - Infusion Topics: Hemochromatosis; Care of Substance Users; Hyperemesis Gravidarum; Cancer Patients' CVCs; Biosimilar Basics

Activity Steps

1 Activity
2 Take Test
3 Activity
4Certificate

Description

By participating in this activity you will earn CRNI Recertification and CE Credit.

This issue contains the following articles:
  • Comparing Care of the Primary and Secondary Hemochromatosis Patients
  • Compassionate Care of the Patient Who Uses Substances: Implications for the Infusion Nurse
  • Hyperemesis Gravidarum: Strategies to Improve Outcomes
  • Experience and Satisfaction of Cancer Patients With a Central Venous Catheter at a Tertiary Hospital in South Korea
  • Biosimilar Basics

Purpose of Activity

To provide infusion nurses with information to increase their knowledge about current issues affecting infusion nursing practice.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Recall the causes and pathophysiology of hemochromatosis and the signs and symptoms, diagnosis, and management of a patient with this condition.
  2. Explain the essential principles of compassionate care of the patient who uses substances.
  3. Select signs and symptoms, risk factors, and potential maternal and fetal complications of hyperemesis gravidarum (HG) and the treatment of a women with this condition.
  4. Identify the discomforts and satisfaction that cancer patients with central venous catheters (CVCs) may experience in daily activities as outpatients.
  5. Explain the characteristics and regulatory aspects of biosimilars, as well as examples and implications for nurses and prescribers.

Disclosures

The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.

Price: $200.00

Credits:

  • ANCC 5.0 CH
  • INCC 10.0 CRNI
  • DC - BON 5.0 CH
  • FL - BON 5.0 CH
  • GA - BON 5.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

The Infusion Nurses Certification Corporation (INCC) has approved this CNE activity for 10 CRNI® recertification units.







Planner
Test Code: JINNR0320
Published: March 2020
Expires: 3/7/2025
Sources: Journal of Infusion Nursing
Required Passing Score: 65/82 (79%)
Authors: Susan Becker, DNP, RN, CNS, CCRN, CCNS; Michelle Knapp, DNP, NP-P, PMHNP-BC, et al.; Kimber Wakefield MacGibbon, BSN, RN; Jeong Yun Park, PhD, RN, APN, et al.; Susan Kleppin, RPh, FASHP
Categories: Acute Care , Addiction , Infusion Therapy , Oncology , Perinatal , Women's Health
Specialties: Acute Care, Advanced Practice Nursing, Ambulatory Care, Critical Care, Infusion, Perinatal
Topics: Biosimilars , Hemochromatosis , Hyperemesis Gravidarum , Infusion , Infusion Nurses Society (INS) , Substance Use Disorders